BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  REGENXBIO Reports First Quarter 2022 Financial Results and Recent Operational Highlights

  REGENXBIO Inc. announced financial results for the first quarter ended March 31, 2022, and recent operational highlights.

  May 4, 2022

   · 

  16 min read
• Business

  DURECT Corporation Reports First Quarter 2022 Financial Results and Update of Programs

  DURECT Corporation announced financial results for the three months ended March 31, 2022 and provided a corporate update.

  May 4, 2022

   · 

  10 min read
• Business

  Protagonist Reports First Quarter 2022 Financial Results and Provides Corporate Update

  Protagonist Therapeutics reported financial results for the first quarter of 2022 ended March 31, 2022 and provided a corporate update.

  May 4, 2022

   · 

  12 min read
• Business

  Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

  Tandem Diabetes Care, Inc. reported its financial results for the quarter ended March 31, 2022 and updated its financial guidance for the year ending December 31, 2022.

  May 4, 2022

   · 

  12 min read
• Business

  MorphoSys AG Reports First Quarter 2022 Financial Results

  Monjuvi® U.S. net product sales of US$ 18.7 million (€ 16.6 million) for the first quarter 2022, a 21% year-over-year growth.

  May 4, 2022

   · 

  12 min read
• Business

  Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results

  Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter March 31, 2022.

  May 4, 2022

   · 

  10 min read
• Business

  Axogen, Inc Reports 2022 First Quarter Financial Results

  Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the first quarter ended March 31, 2022.

  May 4, 2022

   · 

  15 min read
• Business

  Ascendis Pharma A/S Announces First Quarter 2022 Financial Results and Business Update Conference Call on May 11

  Ascendis Pharma A/S announced that the company will hold a conference call and live webcast on Wednesday, May 11, 2022 at 4:30 p.m. Eastern Time to review its first quarter 2022 financial results and provide a business update.

  May 4, 2022

   · 

  4 min read
• Business

  Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments

  Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the first quarter 2022.

  May 4, 2022

   · 

  28 min read
• Business

  OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the first quarter ended March 31, 2022.

  May 4, 2022

   · 

  15 min read